SynAct Pharma AB (STO:SYNACT)
Sweden · Delayed Price · Currency is SEK 17.90
0.00 (0.00%)
Sep 22, 2026, 5:29 PM CET
SynAct Pharma AB Market Cap
SynAct Pharma AB has a market cap or net worth of 1 billion as of September 22, 2026. Its market cap has decreased by -4.30% in one year.
Market Cap
1.00B
Enterprise Value
989.07M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
17.90
ChartMarket Cap Chart
Since July 11, 2016, SynAct Pharma AB's market cap has increased from 63.75M to 1.00B, an increase of 1,472.29%. That is a compound annual growth rate of 30.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 1.00B | -16.83% |
| Dec 30, 2025 | 1.21B | 189.20% |
| Dec 30, 2024 | 416.76M | 32.69% |
| Dec 29, 2023 | 314.09M | -87.00% |
| Dec 30, 2022 | 2.42B | -34.75% |
| Dec 30, 2021 | 3.70B | 242.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Flerie AB | 1.50B |
| BioInvent International AB | 1.44B |
| Genovis AB (publ.) | 1.34B |
| Saniona AB | 1.32B |
| AlzeCure Pharma AB | 1.05B |
| Medivir AB | 1.04B |
| Oncopeptides AB | 992.17M |
| Infant Bacterial Therapeutics AB | 909.32M |